|Application ||WB, IHC|
|Calculated MW||49864 Da|
|Homology||Rat, mouse - 15/16 amino acid residues identical; human - 14/16 amino acid residues identical.|
|Other Names||Alpha-2C adrenergic receptor, Alpha-2 adrenergic receptor subtype C4, Alpha-2C adrenoreceptor, Alpha-2C adrenoceptor, Alpha-2CAR, Adra2c|
|Related products for control experiments||Control peptide antigen (supplied with the antibody free of charge).|
|Target/Specificity||Peptide (C)RRPDGAAYPQ*SGLNDE, corresponding to amino acid residues 192-207 of rat ־±2C-Adrenoceptor with replacement of cysteine 202 (C202) with serine (*S) (Accession P22086). 2nd extracellular loop.|
|Peptide Confirmation||Confirmed by amino acid analysis.|
|Format||Affinity purified antibody, lyophilized powder|
|Reconstitution||50 µl or 0.2 ml deionized water, depending on the sample size.|
|Antibody Concentration After Reconstitution||0.8 mg/ml.|
|Buffer After Reconstitution||Phosphate buffered saline (PBS), pH 7.4, 1% BSA, 0.05% NaN3.|
|Storage Before Reconstitution||Lyophilized powder can be stored intact at room temperature for several weeks. For longer periods, it should be stored at -20°C.|
|Storage After Reconstitution||The reconstituted solution can be stored at 4ºC for up to 2 weeks. For longer periods, small aliquots should be stored at -20ºC or below. Avoid multiple freezing and thawing. The further dilutions should be made using a carrier protein such as BSA (1%). Centrifuge all antibody preparations before use (10000 × g 5 min).|
|Control Antigen Storage Before Reconstitution||Lyophilized powder can be stored intact at room temperature for several weeks. For longer periods, it should be stored at -20°C.|
|Control Antigen Reconstitution||100 µl water.|
|Control Antigen Storage After Reconstitution||-20ºC.|
|Preadsorption Control||1 µg peptide per 1 µg antibody.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Adrenoceptors (also called Adrenergic receptors) are the receptors for the catecholamines adrenaline and noradrenaline (called epinephrine and norepinephrine in the United States). Adrenaline and noradrenaline play important roles in the control of blood pressure, myocardial contractile rate and force, airway reactivity, and a variety of metabolic and central nervous system functions. The Adrenoceptors are members of the G-Protein Coupled Receptor (GPCR) superfamily of membrane proteins. They share a common structure of seven putative transmembrane domains, an extracellular N-terminus, and a cytoplasmic C- terminus.The Adrenoceptors are divided into three types: α1, α2 and β-Adrenoceptors. Each type is further divided into at least three subtypes: α1A, α1B, α1D, α2A, α2B, α2C, β1, β2, β31,2. The Adrenoceptors are expressed in nearly all peripheral tissues and in the central nervous system1,2. The α2C-Adrenoceptor subtype was identified by binding studies in the opossum kidney and in cell lines from this organ (OK cells)3,4. Surprisingly, the α2C-Adrenoceptor subtype seems not to play a major role in cardiovascular regulation or the other classical effects of α2-Adrenergic receptors5. Some researchers have suggested that the α2C-Adrenoceptor subtype may play a role in modulating motor behaviour and perhaps in memory processes6,7. Abgent is pleased to offer a highly specific antibody directed against an extracellular epitope of rat α2C-Adrenoceptor. Anti-α2C-Adrenoceptor (extracellular) antibody (#AG1374) can be used for western blot and immunohistochemistry applications. It has been designed to recognize α2C-Adrenoceptor from rat, mouse and human samples.
1. IUPHAR RECEPTOR DATABASE | ADRENOCEPTORS.
2. Piascik, M.T. and Perez, D. M. (2001) J. Pharmacol. Exp. Ther. 298, 403.
3. Murphy, T.J. and Bylund, D.B. (1988) J. Pharmacol. Exp. Ther. 244, 571.
4. Blaxall, H.S. et al. (1991) J. Pharmacol. Exp. Ther. 2559, 323.
5. Bjorklind M. et al. (1999) Neuroscience 88, 1187.
6. Tanila H. et al. (1999) Eur. J. Neurosci. 11, 599.
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at email@example.com.